Screening biomaterials for stimulation of nitric oxide-mediated inflammation

Journal of Biomedical Materials Research - Part A

Volumn 90, Issue 1, 2009, Pages 82-93

  Lyle, Daniel B ^a   Shallcross, Jonathan C ^a   Durfor, Charles N ^a   Hitchins, Victoria M ^a   Breger, Joyce C ^a   Langone, John J ^a  

^a CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

Author keywords

Biomaterials; Hyaluronic acid; Inflammation; Macrophage; Nitric oxide

Indexed keywords

CONCENTRATION OF; DIAMINONAPHTHALENE; E. COLI; HYALURONIC ACID; HYALURONIC ACIDS; IMMUNE REACTION; IMPLANTED DEVICE; IMPLANTED MEDICAL DEVICES; IN-VITRO; INFLAMMATION; INFLAMMATORY REACTION; INFLAMMATORY RESPONSE; LIPOPOLYSACCHARIDE; NUCLEAR FACTORS; PARTHENOLIDE; TIME POINTS;

CELL CULTURE; ESCHERICHIA COLI; HYDROXYLATION; MACROPHAGES; NITRIC OXIDE; ORGANIC ACIDS; PATHOLOGY; POLYSACCHARIDES;

BIOLOGICAL MATERIALS;

BIOMATERIAL; ENDOTOXIN; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRITE; PARTHENOLIDE; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; INFLAMMATION; MACROPHAGE; NONHUMAN; SCREENING;

2-NAPHTHYLAMINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOCOMPATIBLE MATERIALS; CELL LINE; HUMANS; HYALURONIC ACID; INFLAMMATION; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MACROPHAGES; MATERIALS TESTING; MICE; NITRIC OXIDE; NITRITES; SESQUITERPENES;

EID: 66849104321     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32060     Document Type: Article

References (50)

1. Tang L, Eaton JW. Inflammatory responses to biomaterials. Am J Clin Pathol 1995;103:466-572.
2. Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ. Mediation of biomaterial-cell interactions by adsorbed proteins: A review. Tissue Eng 2005;11:1-18. (Pubitemid 40515171)
3. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005;29:34-48. (Pubitemid 40685159)
4. Ryrfeldt A. Drug-induced inflammatory responses to the lung. Toxicol Lett 2000;112/113:171-176. (Pubitemid 30138120)
5. Nakagawa Y, Murai T, Hasegawa C, Hirata M, Tsuchiya T, Yagami T, Haishima Y. Endotoxin contamination in wound dressings made of natural biomaterials. Biomed Mater Res B Appl Biomater 2003;66:347-355. (Pubitemid 37522427)
6. Laskin DL, Pendino KJ. Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol 1995;35:655-677.
7. ASTM. F1903-98 (reapproved 2003): Standard practice for testing for biological responses to particles in vitro. In: Annual Book of ASTM Standards, West Conshohocken, PA, Vol 13.01. ASTM; 2003. p 1003-1006.
8. Chapekar SM, Zaremba TG, Kuester RK, Hitchins VM. Synergistic induction of tumor necrosis factor α by bacterial lipopolysaccharide and lipoteichoic acid in combination with polytetrafluoroethylene particles in a murine macrophage cell line RAW 264.7. J Biomed Mater Res 1996;31:251-256. (Pubitemid 26170799)
9. Campa VM, Iglesias JM, Carcedo MT, Rodriguez R, Riera J, Ramos S, Lazo PS. Polyinosinic acid induces TNF and NO production as well as NF-kappaB and AP-1 transcriptional activation in the monocyte/macrophage cell line RAW 264.7. Inflamm Res 2005;54:328-337. (Pubitemid 41291656)
10. Tsikas D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res 2005;39:797-815. (Pubitemid 40975073)
11. Le Page C, Sanceau J, Drapier JC, Wietzerbin J. Differential expression of inducible NO synthase in two murine macrophage cell lines. Immunology 1996;89:274-280. (Pubitemid 26340134)
12. Eppley BL, Dadvand B. Injectable soft-tissue fillers: Clinical overview. Plast Reconstr Surg 2006;118:98e-106e. (Pubitemid 44412913)
13. Waddell DD. Viscosupplementation with hyaluronans for osteoarthritis of the knee: Clinical efficacy and economic implications. Drugs Aging 2007;24:629-642. (Pubitemid 47294712)
14. Miranda M, Bosch-Morell F, Belda JI, Garcia-Manzanares MD, Barcia J, Alio JL, Romero FJ. Protective effect of viscoelastics against retina lipid peroxidation. Ophthalmic Res 2007;39:260-264. (Pubitemid 47557246)
15. Bae KH, Yoon JJ, Park TG. Fabrication of hyaluronic acid hydrogel beads for cell encapsulation. Biotechnol Prog 2006;22:297-302.
16. Leach JB, Schmidt CE. Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds. Biomaterials 2005;26:125-135. (Pubitemid 38789095)
17. Allison DD, Grande-Allen KJ. Review. Hyaluronan: A powerful tissue engineering tool. Tissue Eng 2006;12:2131-2140.
18. Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002;28:491-494. (Pubitemid 34686633)
19. Andre P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA - Q-Medical. Sweden) in European countries: A retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol 2004;18:422-425. (Pubitemid 38967974)
20. De Boulle K. Management of complications after implantation of fillers. J Cosmet Dermatol 2004;3:2-15.
21. Chen AL, Desai P, Adler EM, Di Cesare PE. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: A report of six cases. J Bone Joint Surg Am 2002;84:1142-1147. (Pubitemid 34907388)
22. Dick HB, Augustin AJ, Pakula T, Pfeiffer N. Endotoxins in ophthalmic viscosurgical devices. Eur J Ophthalmol 2003;13:176-184. (Pubitemid 36433862)
23. Shiedlin A, Bigelow R, Christopher W, Arbabi S, Yang L, Maier RV, Wainwright N, Childs A, Miller RJ. Evaluation of hyaluronan from different sources: Streptococcus zooepidemicus, rooster comb, bovine vitreous, and human umbilical cord. Biomacromolecules 2004;5:2122-2127.
24. Noble PW, Lake FR, Henson PM, Riches DWH. Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-α-dependent mechanism in murine macrophages. J Clin Invest 1993;91:2368-2377. (Pubitemid 23182485)
25. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. J Clin Invest 1996;98:2403-2413.
26. Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S, Kudo T. The biological effects of antiadhesion agents on activated RAW264.7 macrophages. J Biomed Mater Res 2002;61:628-633. (Pubitemid 34721507)
27. Tian JY, Sorensen ES, Butler WT, Lopez CA, Sy MS, Desai NK, Denhardt DT. Regulation of NO synthesis induced by inflammatory mediators in RAW264.7 cells: Collagen prevents inhibition by osteopontin. Cytokine 2000;12:450-457. (Pubitemid 30449842)
28. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993;214:11-16. (Pubitemid 23300346)
29. Nussler AK, Glanemann M, Schirmeier A, Liu L, Nussler NC. Fluorometric measurement of nitrite/nitrate by 2,3-diaminonapththalene. Nat Protoc 2006;5:2223-2226.
30. Stuehr DJ, Marletta MA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res 1987;47:5590-5594. (Pubitemid 18046749)
31. Peterbauer A, Eperon S, Jungi TW, Werner ER, Werner-Felmayer G. Interferon-γ-primed monocytoid cell lines: Optimizing their use for in vitro detection of bacterial pyrogens. J Immunol Methods 2000;233:67-76. (Pubitemid 30058236)
32. Hehner SP, Hofmann TG, Droge W, Schmitz ML. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IKB kinase complex. J Immunol 1999;163:5617-5623.
33. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-γ: An overview of signals, mechanisms and functions. J Leukoc Biol 2004;75:163-189.
34. Cooper JF. Voluntary standards for hemodialysis water. LAL Times 2001;8:1-5.
35. Pontoriero G, Pozzoni P, Andrulli S, Locatelli F. The quality of dialysis water. Nephrol Dial Transplant 2003;18:21-25. (Pubitemid 37098604)
36. ANSI/AAMI RD52:2004. Dialysate for hemolysis; and RD61: 2006. Concentrates for hemolysis; www.aami.org.
37. Fujiwara N, Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 2005;4:281-286. (Pubitemid 40873112)
38. Stout RD. Macrophage activation by T cells: Cognate and non-cognate signals. Curr Opin Immunol 1993;5:398-403. (Pubitemid 23197452)
39. ASTM F 2347-03. Standard guide for characterization and testing of hyaluronan as starting materials intended for use in biomedical and tissue engineered medical product applications. Annual Book of ASTM Standards 2006;13.01:1377-1385.
40. FDA Interim Guidance for Human and Veterinary Drug Products and Biologicals. Rockville MD, Food and Drug Administration, Department of Health and Human Services, 1991.
41. Hitchins VM, Merrit K. Decontaminating particles exposed to bacterial endotoxin (LPS). J Biomed Mater Res 1999;46:434-437. (Pubitemid 29293768)
42. Gorbet MB, Sefton MV. Endotoxin: The uninvited guest. Biomaterials 2005;26:6811-6817.
43. US Department of Health and Human Services/Public Health Services/Food and Drug Administration. Guideline on validation of the limulus amebocyte lysate test as an end-product endotoxin test for human and animal parental drugs, biological products and medical devices. Rockville, MD. 1987. p 1-30.
44. Wiegand F, Kroncke KD, Kolb-Bachofen V. Macrophage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets. Transplantation 1993;5:1206-1212.
45. Garcia X, Stein F. Nitric oxide. Semin Pediatr Infect Dis 2006;17:55-57. (Pubitemid 43963526)
46. Kroncke KD, Kolb-Bachofen V, Berschick B, Burkart V, Kolb H. Activated macrophages kill pancreatic syngeneic islet cells via arginine-dependent nitric oxide generation. Biochem Biophys Res Commun 1991;175:752-758.
47. Korhonen R, Lahti A, Kankaanranta H, Moilanen E. Nitric oxide production and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005;4:471-479. (Pubitemid 41052412)
48. Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004;423:12-22. (Pubitemid 38202218)
49. Le Page C, Sanceau J, Drapier JC, Wietzerbin J. Differential expression of inducible NO synthase in two murine macrophage cell lines. Immunology 1996;89:274-280. (Pubitemid 26340134)
50. Nakagawa Y, Maeda H, Murai T. Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: Comparison with a human whole blood culture test system and with the rabbit pyrogen test. Clin Diagn Lab Immunol 2002;9:588-597. (Pubitemid 34538219)